ES3063764T3 - C10-alkylene substituted 13-membered macrolides and uses thereof - Google Patents
C10-alkylene substituted 13-membered macrolides and uses thereofInfo
- Publication number
- ES3063764T3 ES3063764T3 ES19821351T ES19821351T ES3063764T3 ES 3063764 T3 ES3063764 T3 ES 3063764T3 ES 19821351 T ES19821351 T ES 19821351T ES 19821351 T ES19821351 T ES 19821351T ES 3063764 T3 ES3063764 T3 ES 3063764T3
- Authority
- ES
- Spain
- Prior art keywords
- membered macrolides
- macrolides
- alkylene substituted
- thirteen
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862769383P | 2018-11-19 | 2018-11-19 | |
| PCT/US2019/062030 WO2020106627A1 (en) | 2018-11-19 | 2019-11-18 | C10-alkylene substituted 13-membered macrolides and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES3063764T3 true ES3063764T3 (en) | 2026-04-20 |
Family
ID=68916562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES19821351T Active ES3063764T3 (en) | 2018-11-19 | 2019-11-18 | C10-alkylene substituted 13-membered macrolides and uses thereof |
Country Status (22)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202313065A (zh) * | 2021-05-28 | 2023-04-01 | 美商季卡尼醫療公司 | 用於治療遺傳疾病之化合物 |
| WO2023250513A1 (en) * | 2022-06-24 | 2023-12-28 | Zikani Therapeutics, Inc. | 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation |
| JP2025530776A (ja) | 2022-09-01 | 2025-09-17 | ジカニ セラピューティクス, インコーポレイテッド | 13員環マクロライドを使用した家族性大腸腺腫症の処置 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP980189B1 (en) * | 1998-04-06 | 2004-04-30 | Pliva Pharm & Chem Works | Novel 15-membered lactams ketolides |
| UA70972C2 (uk) * | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членні азаліди і їх застосування як антибіотиків |
| NZ526120A (en) * | 1999-11-09 | 2005-02-25 | Pfizer Prod Inc | 13-membered azalides and their use as antibiotic agents |
| JP2004516233A (ja) * | 2000-04-27 | 2004-06-03 | ファイザー・プロダクツ・インク | 哺乳動物の細菌若しくは原生動物感染症を治療するか又は予防するためのアザライド抗生組成物の使用 |
| JP4311203B2 (ja) * | 2001-08-08 | 2009-08-12 | 大正製薬株式会社 | 11a−アザライド化合物及びその製造方法 |
| HRP20030381B1 (en) * | 2003-05-14 | 2007-05-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A |
| WO2004108744A2 (en) * | 2003-05-19 | 2004-12-16 | Prasad K Deshpande | Azalides and azaketolides having antimicrobial activity |
| WO2005042554A1 (en) * | 2003-10-30 | 2005-05-12 | Rib-X Pharmaceuticals, Inc. | Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
| RU2008106915A (ru) * | 2005-07-26 | 2009-09-10 | Меркле Гмбх (De) | Макролидные конъюгаты пирролиновых и индолизиновых соединений |
| WO2007091393A1 (ja) * | 2006-02-07 | 2007-08-16 | Taisho Pharmaceutical Co., Ltd. | 10a-アザライド化合物 |
| EP2588084B1 (en) * | 2010-07-01 | 2023-11-22 | Elanco Tiergesundheit AG | Antibiotic compositions comprising tulathromycin |
| CN102993250B (zh) * | 2011-07-06 | 2016-02-10 | 洛阳惠中兽药有限公司 | C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物 |
| EP4095146A1 (en) | 2013-04-04 | 2022-11-30 | President And Fellows Of Harvard College | Macrolides and methods of their preparation and use |
| JP2017531663A (ja) | 2014-10-08 | 2017-10-26 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 14員ケトライドならびにそれらの調製および使用の方法 |
| WO2016154591A1 (en) | 2015-03-25 | 2016-09-29 | President And Fellows Of Harvard College | Macrolides with modified desosamine sugars and uses thereof |
| EP3277701A4 (en) | 2015-03-25 | 2019-03-06 | President and Fellows of Harvard College | SYNTHESIS OF DESOSAMINES |
| CA3000709A1 (en) * | 2015-10-01 | 2017-04-06 | Memorial Sloan-Kettering Cancer Center | Inhibitors of menaquinone biosynthesis |
| US11673910B2 (en) * | 2017-04-28 | 2023-06-13 | Zikani Therapeutics, Inc. | Macrolides with modified desosamine sugars and uses thereof |
-
2019
- 2019-11-18 AU AU2019385333A patent/AU2019385333B2/en active Active
- 2019-11-18 CA CA3120148A patent/CA3120148A1/en active Pending
- 2019-11-18 KR KR1020217018876A patent/KR102929869B1/ko active Active
- 2019-11-18 DK DK19821351.4T patent/DK3883647T3/da active
- 2019-11-18 BR BR112021009624-8A patent/BR112021009624A2/pt unknown
- 2019-11-18 US US17/294,878 patent/US12552825B2/en active Active
- 2019-11-18 RS RS20260338A patent/RS68104B1/sr unknown
- 2019-11-18 SG SG11202105227QA patent/SG11202105227QA/en unknown
- 2019-11-18 EP EP25226862.8A patent/EP4737470A3/en active Pending
- 2019-11-18 IL IL283194A patent/IL283194B2/en unknown
- 2019-11-18 ES ES19821351T patent/ES3063764T3/es active Active
- 2019-11-18 WO PCT/US2019/062030 patent/WO2020106627A1/en not_active Ceased
- 2019-11-18 HR HRP20260395TT patent/HRP20260395T1/hr unknown
- 2019-11-18 MX MX2021005423A patent/MX2021005423A/es unknown
- 2019-11-18 SI SI201931026T patent/SI3883647T1/sl unknown
- 2019-11-18 EP EP19821351.4A patent/EP3883647B1/en active Active
- 2019-11-18 PL PL19821351.4T patent/PL3883647T3/pl unknown
- 2019-11-18 JP JP2021527829A patent/JP7551610B2/ja active Active
- 2019-11-18 PT PT198213514T patent/PT3883647T/pt unknown
- 2019-11-18 SM SM20260094T patent/SMT202600094T1/it unknown
- 2019-11-18 FI FIEP19821351.4T patent/FI3883647T3/fi active
- 2019-11-18 CN CN201980086676.8A patent/CN113573779A/zh active Pending
- 2019-11-18 LT LTEPPCT/US2019/062030T patent/LT3883647T/lt unknown
-
2024
- 2024-09-04 JP JP2024152316A patent/JP2025000636A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL283194B1 (en) | 2024-11-01 |
| EP3883647B1 (en) | 2026-02-11 |
| SMT202600094T1 (it) | 2026-03-09 |
| RS68104B1 (sr) | 2026-06-30 |
| SI3883647T1 (sl) | 2026-04-30 |
| MX2021005423A (es) | 2021-09-08 |
| IL283194A (en) | 2021-06-30 |
| JP7551610B2 (ja) | 2024-09-17 |
| IL283194B2 (en) | 2025-03-01 |
| FI3883647T3 (fi) | 2026-03-25 |
| JP2025000636A (ja) | 2025-01-07 |
| EP4737470A3 (en) | 2026-07-22 |
| PT3883647T (pt) | 2026-02-26 |
| DK3883647T3 (da) | 2026-03-23 |
| SG11202105227QA (en) | 2021-06-29 |
| PL3883647T3 (pl) | 2026-06-01 |
| US12552825B2 (en) | 2026-02-17 |
| EP4737470A2 (en) | 2026-05-06 |
| JP2022507776A (ja) | 2022-01-18 |
| AU2019385333B2 (en) | 2025-04-17 |
| LT3883647T (lt) | 2026-03-25 |
| HRP20260395T1 (hr) | 2026-05-08 |
| EP3883647A1 (en) | 2021-09-29 |
| KR20210133950A (ko) | 2021-11-08 |
| CA3120148A1 (en) | 2020-05-28 |
| US20230093692A1 (en) | 2023-03-23 |
| WO2020106627A1 (en) | 2020-05-28 |
| BR112021009624A2 (pt) | 2021-08-10 |
| KR102929869B1 (ko) | 2026-02-23 |
| AU2019385333A1 (en) | 2021-07-01 |
| CN113573779A (zh) | 2021-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY38476A (es) | Inhibidores de arg1 y/o arg2 | |
| NI201900085A (es) | 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas | |
| CL2018002920A1 (es) | Nuevos derivados de pirazolopirimidina | |
| CY1124239T1 (el) | Ενωσεις αμινο-τριαζολοπυριδινης και χρηση αυτων στην αγωγη του καρκινου | |
| CL2018000292A1 (es) | Compuestos farmacéuticos | |
| UA124347C2 (uk) | Циклічна динуклеотидна сполука | |
| CO2019011877A2 (es) | Nuevos derivados de pirazol bicíclicos | |
| MX2016015218A (es) | Antibioticos macrociclicos de amplio espectro. | |
| BR112017000246A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal | |
| CL2022003703A1 (es) | Compuestos antibióticos, métodos de fabricación de los mismos, composiciones farmacéuticas conteniendo los mismos y usos | |
| CO2019010001A2 (es) | Antibióticos macrociclicos de amplio espectro | |
| WO2017024059A8 (en) | Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use | |
| MX386742B (es) | Antibióticos de amplio espectro macrocíclico. | |
| MX2019013291A (es) | Compuestos y metodos para tratar infecciones bacterianas. | |
| MX387476B (es) | Antibióticos de amplio espectro macrocíclico. | |
| EP4286001A3 (en) | Benzoylglycine derivatives and methods of making and using same | |
| EA201890412A1 (ru) | АНТИБАКТЕРИАЛЬНЫЕ АГЕНТЫ, СОДЕРЖАЩИЕ ПИРАЗИНО[2,3-b][1,4]ОКСАЗИН-3-ОН ИЛИ РОДСТВЕННУЮ КОЛЬЦЕВУЮ СИСТЕМУ | |
| MX2018001022A (es) | Antibiotico aminoglucosido novedoso efectivo contra bacterias resistentes a multiples farmacos. | |
| MX2021009443A (es) | Composiciones que contienen bacterias productoras de bacillaeno o preparaciones de las mismas. | |
| MX2021005421A (es) | Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos. | |
| CL2017001276A1 (es) | Derivados de benzotiazol antibacterianos | |
| MX2021005423A (es) | Macrolidos de 13 miembros sustituidos con c10-alquileno y usos de los mismos. | |
| MX2017015988A (es) | Derivados de manosa para tratar infecciones bacterianas. | |
| BR112022010204A2 (pt) | Derivado do anel de piridina fusionado, método de preparação para o mesmo e uso farmacêutico do mesmo | |
| WO2019070709A8 (en) | Compounds for treating or preventing flavivirus infections |